Independent Finnish developer Remedy Entertainment reported a sharp revenue decline in its H1 2026 financial report released today, but the studio says early demand signals for its upcoming sequel, CONTROL Resonant , remain strong ahead of its September 24 launch.
Remedy's second-quarter (April–June 2026) revenue fell 40.0% year-over-year to €10.2 million , down from €16.9 million in the same period last year. For the full first half of 2026, revenue was down by 23.1% to €23.3 million (from €30.3 million), though EBITDA remained marginally positive at €0.5 million and cash flow from operations improved to €7.6 million, aided by the favorable timing of incoming payments.
CEO Jean-Charles Gaudechon , who took over the role in March 2026, attributed the drop mainly to a tough comparison: Q2 2025 included a large revenue bump from the launch of FBC: Firebreak , with initial subscription-service accruals inflating last year's figures. Development fees from the Max Payne 1&2 remake and CONTROL Resonant totaled €6.4 million for the quarter, while game sales and royalties dropped to €3.8 million from €9.5 million.
Despite the year-over-year decline, it's not at all doom and gloom: Remedy noted that the original Control continued growing sales momentum in Q2, partly driven by renewed interest in the franchise from the sequel's marketing push, while Alan Wake 2 also crossed an important milestone during the quarter, with lifetime sales exceeding 3 million copies .
The centerpiece of today's report is, as you'd expect, the imminent launch of CONTROL Resonant , confirmed for a worldwide release on September 24, 2026 . Remedy says the response has been strongly positive, singling out the game's shift toward faster, melee-led combat as the most debated (but ultimately well-received) change from the original game. As of today, the game has already surpassed 1.5 million wishlists across platforms.
On PlayStation specifically, Remedy's internal analytics reportedly show CONTROL Resonant ranking among the top three most pre-ordered games in the US, Germany, and Brazil during its post-announcement campaign window. Marketing spend for the game ramped up significantly during Q2, which the company explicitly flagged as a driver of the quarter's weaker profitability: other operating expenses rose by €1.7 million largely due to CONTROL Resonant promotional activity.
On the development side, Remedy listed three active projects: CONTROL Resonant (full production, self-published), a still-unnamed new project that has now advanced to "production readiness," and the Max Payne 1&2 remake being developed for Rockstar Games, also in full production.
Despite the rough quarter, Remedy left its full-year 2026 outlook intact, still expecting revenue and EBITDA to grow year-over-year once CONTROL Resonant ships. The studio reiterated its ambitious 2030 strategic targets: doubling 2024 revenue by 2027 and reaching a 30% EBITDA margin by the same year, sustained through the rest of the strategy period.
Headcount stood at 379 employees at the end of the period, down slightly from 385 a year earlier, while the company's cash and liquid investments totaled €29.6 million, giving it a net cash position of €11.8 million heading into its biggest launch window to date .
Follow Wccftech on Google to get more of our news coverage in your feeds.